1. Home
  2. GGB vs KRYS Comparison

GGB vs KRYS Comparison

Compare GGB & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gerdau S.A.

GGB

Gerdau S.A.

HOLD

Current Price

$4.34

Market Cap

8.8B

Sector

Industrials

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$345.86

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGB
KRYS
Founded
1901
2015
Country
Brazil
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.6B
IPO Year
2000
2017

Fundamental Metrics

Financial Performance
Metric
GGB
KRYS
Price
$4.34
$345.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$5.38
$297.60
AVG Volume (30 Days)
12.1M
508.3K
Earning Date
04-27-2026
05-04-2026
Dividend Yield
2.30%
N/A
EPS Growth
N/A
128.00
EPS
N/A
3.62
Revenue
N/A
$389,130,000.00
Revenue This Year
$4.59
$38.74
Revenue Next Year
$3.46
$32.53
P/E Ratio
$13.89
$93.10
Revenue Growth
N/A
33.94
52 Week Low
$2.98
$143.09
52 Week High
$5.18
$382.54

Technical Indicators

Market Signals
Indicator
GGB
KRYS
Relative Strength Index (RSI) 34.04 54.09
Support Level $3.95 $253.89
Resistance Level $4.86 $382.33
Average True Range (ATR) 0.16 10.03
MACD -0.08 1.62
Stochastic Oscillator 15.00 98.36

Price Performance

Historical Comparison
GGB
KRYS

About GGB Gerdau S.A.

Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as Semi-finished products (Billets, Blooms and Slabs), Special bar quality, Common Long Rolled Products, Dawn products, Merchant bar, Beams, Rebar, Piling, Iron Ore and Others. The company's geographical segment includes Brazil Segment; North America Segment; and South America Segment. It derives the majority of its revenue from the Brazil Operations segment, which includes the long, flat and special steel operations and the iron ore operation located in Brazil and joint ventures and associated companies located in Brazil.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: